BMPR2 and pulmonary arterial hypertension: Amongst other factors responsible for this uncontrolled proliferative status in PAH, is the deficiency of the Bone Morphogenetic Protein Receptor Type 2 (BMPR2) signaling pathway, which represents an essential characteristic of PASMCs from patients with PAH [49].